Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion

Linda Papa, Michelle M. Ramia, Damyan Edwards, Brian D. Johnson, Semyon Slobounov

Research output: Contribution to journalReview article

61 Citations (Scopus)

Abstract

The aim of this study was to systematically review clinical studies examining biofluid biomarkers of brain injury for concussion in athletes. Data sources included PubMed®, MEDLINE®, and the Cochrane Database from 1966 to October 2013. Studies were included if they recruited athletes participating in organized sports who experienced concussion or head injury during a sports-related activity and had brain injury biomarkers measured. Acceptable research designs included experimental, observational, and case-control studies. Review articles, opinion papers, and editorials were excluded. After title and abstract screening of potential articles, full texts were independently reviewed to identify articles that met inclusion criteria. A composite evidentiary table was then constructed and documented the study title, design, population, methods, sample size, outcome measures, and results. The search identified 52 publications, of which 13 were selected and critically reviewed. All of the included studies were prospective and were published either in or after the year 2000. Sports included boxing (six studies), soccer (five studies), running/jogging (two studies), hockey (one study), basketball (one study), cycling (one study), and swimming (one study). The majority of studies (92%) had fewer than 100 patients. Three studies (23%) evaluated biomarkers in cerebrospinal fluid (CSF), one in both serum and CSF, and 10 (77%) in serum exclusively. There were 11 different biomarkers assessed, including S100β, glial fibrillary acidic protein, neuron-specific enolase, tau, neurofilament light protein, amyloid beta, brain-derived neurotrophic factor, creatine kinase and heart-type fatty acid binding protein, prolactin, cortisol, and albumin. A handful of biomarkers showed a correlation with number of hits to the head (soccer), acceleration/deceleration forces (jumps, collisions, and falls), postconcussive symptoms, trauma to the body versus the head, and dynamics of different sports. Although there are no validated biomarkers for concussion as yet, there is potential for biomarkers to provide diagnostic, prognostic, and monitoring information postinjury. They could also be combined with neuroimaging to assess injury evolution and recovery.

Original languageEnglish (US)
Pages (from-to)661-673
Number of pages13
JournalJournal of Neurotrauma
Volume32
Issue number10
DOIs
StatePublished - May 15 2015

Fingerprint

Athletes
Brain Injuries
Sports
Biomarkers
Soccer
Cerebrospinal Fluid
Brain Concussion
Head
Boxing
Jogging
Hockey
Basketball
Fatty Acid-Binding Proteins
Deceleration
Phosphopyruvate Hydratase
Information Storage and Retrieval
Glial Fibrillary Acidic Protein
Brain-Derived Neurotrophic Factor
Wounds and Injuries
Creatine Kinase

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Papa, Linda ; Ramia, Michelle M. ; Edwards, Damyan ; Johnson, Brian D. ; Slobounov, Semyon. / Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion. In: Journal of Neurotrauma. 2015 ; Vol. 32, No. 10. pp. 661-673.
@article{7895c7fed8ec40dc9b90989b8fb4ae08,
title = "Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion",
abstract = "The aim of this study was to systematically review clinical studies examining biofluid biomarkers of brain injury for concussion in athletes. Data sources included PubMed{\circledR}, MEDLINE{\circledR}, and the Cochrane Database from 1966 to October 2013. Studies were included if they recruited athletes participating in organized sports who experienced concussion or head injury during a sports-related activity and had brain injury biomarkers measured. Acceptable research designs included experimental, observational, and case-control studies. Review articles, opinion papers, and editorials were excluded. After title and abstract screening of potential articles, full texts were independently reviewed to identify articles that met inclusion criteria. A composite evidentiary table was then constructed and documented the study title, design, population, methods, sample size, outcome measures, and results. The search identified 52 publications, of which 13 were selected and critically reviewed. All of the included studies were prospective and were published either in or after the year 2000. Sports included boxing (six studies), soccer (five studies), running/jogging (two studies), hockey (one study), basketball (one study), cycling (one study), and swimming (one study). The majority of studies (92{\%}) had fewer than 100 patients. Three studies (23{\%}) evaluated biomarkers in cerebrospinal fluid (CSF), one in both serum and CSF, and 10 (77{\%}) in serum exclusively. There were 11 different biomarkers assessed, including S100β, glial fibrillary acidic protein, neuron-specific enolase, tau, neurofilament light protein, amyloid beta, brain-derived neurotrophic factor, creatine kinase and heart-type fatty acid binding protein, prolactin, cortisol, and albumin. A handful of biomarkers showed a correlation with number of hits to the head (soccer), acceleration/deceleration forces (jumps, collisions, and falls), postconcussive symptoms, trauma to the body versus the head, and dynamics of different sports. Although there are no validated biomarkers for concussion as yet, there is potential for biomarkers to provide diagnostic, prognostic, and monitoring information postinjury. They could also be combined with neuroimaging to assess injury evolution and recovery.",
author = "Linda Papa and Ramia, {Michelle M.} and Damyan Edwards and Johnson, {Brian D.} and Semyon Slobounov",
year = "2015",
month = "5",
day = "15",
doi = "10.1089/neu.2014.3655",
language = "English (US)",
volume = "32",
pages = "661--673",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion. / Papa, Linda; Ramia, Michelle M.; Edwards, Damyan; Johnson, Brian D.; Slobounov, Semyon.

In: Journal of Neurotrauma, Vol. 32, No. 10, 15.05.2015, p. 661-673.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion

AU - Papa, Linda

AU - Ramia, Michelle M.

AU - Edwards, Damyan

AU - Johnson, Brian D.

AU - Slobounov, Semyon

PY - 2015/5/15

Y1 - 2015/5/15

N2 - The aim of this study was to systematically review clinical studies examining biofluid biomarkers of brain injury for concussion in athletes. Data sources included PubMed®, MEDLINE®, and the Cochrane Database from 1966 to October 2013. Studies were included if they recruited athletes participating in organized sports who experienced concussion or head injury during a sports-related activity and had brain injury biomarkers measured. Acceptable research designs included experimental, observational, and case-control studies. Review articles, opinion papers, and editorials were excluded. After title and abstract screening of potential articles, full texts were independently reviewed to identify articles that met inclusion criteria. A composite evidentiary table was then constructed and documented the study title, design, population, methods, sample size, outcome measures, and results. The search identified 52 publications, of which 13 were selected and critically reviewed. All of the included studies were prospective and were published either in or after the year 2000. Sports included boxing (six studies), soccer (five studies), running/jogging (two studies), hockey (one study), basketball (one study), cycling (one study), and swimming (one study). The majority of studies (92%) had fewer than 100 patients. Three studies (23%) evaluated biomarkers in cerebrospinal fluid (CSF), one in both serum and CSF, and 10 (77%) in serum exclusively. There were 11 different biomarkers assessed, including S100β, glial fibrillary acidic protein, neuron-specific enolase, tau, neurofilament light protein, amyloid beta, brain-derived neurotrophic factor, creatine kinase and heart-type fatty acid binding protein, prolactin, cortisol, and albumin. A handful of biomarkers showed a correlation with number of hits to the head (soccer), acceleration/deceleration forces (jumps, collisions, and falls), postconcussive symptoms, trauma to the body versus the head, and dynamics of different sports. Although there are no validated biomarkers for concussion as yet, there is potential for biomarkers to provide diagnostic, prognostic, and monitoring information postinjury. They could also be combined with neuroimaging to assess injury evolution and recovery.

AB - The aim of this study was to systematically review clinical studies examining biofluid biomarkers of brain injury for concussion in athletes. Data sources included PubMed®, MEDLINE®, and the Cochrane Database from 1966 to October 2013. Studies were included if they recruited athletes participating in organized sports who experienced concussion or head injury during a sports-related activity and had brain injury biomarkers measured. Acceptable research designs included experimental, observational, and case-control studies. Review articles, opinion papers, and editorials were excluded. After title and abstract screening of potential articles, full texts were independently reviewed to identify articles that met inclusion criteria. A composite evidentiary table was then constructed and documented the study title, design, population, methods, sample size, outcome measures, and results. The search identified 52 publications, of which 13 were selected and critically reviewed. All of the included studies were prospective and were published either in or after the year 2000. Sports included boxing (six studies), soccer (five studies), running/jogging (two studies), hockey (one study), basketball (one study), cycling (one study), and swimming (one study). The majority of studies (92%) had fewer than 100 patients. Three studies (23%) evaluated biomarkers in cerebrospinal fluid (CSF), one in both serum and CSF, and 10 (77%) in serum exclusively. There were 11 different biomarkers assessed, including S100β, glial fibrillary acidic protein, neuron-specific enolase, tau, neurofilament light protein, amyloid beta, brain-derived neurotrophic factor, creatine kinase and heart-type fatty acid binding protein, prolactin, cortisol, and albumin. A handful of biomarkers showed a correlation with number of hits to the head (soccer), acceleration/deceleration forces (jumps, collisions, and falls), postconcussive symptoms, trauma to the body versus the head, and dynamics of different sports. Although there are no validated biomarkers for concussion as yet, there is potential for biomarkers to provide diagnostic, prognostic, and monitoring information postinjury. They could also be combined with neuroimaging to assess injury evolution and recovery.

UR - http://www.scopus.com/inward/record.url?scp=84929993451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929993451&partnerID=8YFLogxK

U2 - 10.1089/neu.2014.3655

DO - 10.1089/neu.2014.3655

M3 - Review article

C2 - 25254425

AN - SCOPUS:84929993451

VL - 32

SP - 661

EP - 673

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 10

ER -